EYPT vs NVDA · rev $1.2M vs P/E 58, rev $96.22B
Eyepoint Pharmaceuticals Inc (EYPT) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
EYPT currently screens at market cap $1.10B. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the EYPT and NVDA stock pages for the full models.
Not investment advice.